KINIKSA PHARMACEUTICALS, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.08 USD | +3.61% |
|
+12.30% | +14.48% |
| 04-23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
| 04-23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Bio Therapeutic Drugs | +3.61% | +12.30% | +14.48% | +46.68% | +29.55% | 1.42B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KNSA Stock
- Charts Kiniksa Pharmaceuticals, Ltd.
- Comparison Chart
